Form 4 for IBO IMPACT BIOMEDICAL INC.
Accepted 2025-03-24 00:00:00 ET · period of report 2024-12-02 · accession 0001641172-25-000403 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-03-24 | 2024-12-02+ | IBO | DSS, INC. | 10% | S - Sale | $4.68 | -53.3K | 53.1K | -50% | -$249.4K |
| I | 2025-03-24 | 2025-03-20 | IBO | DSS, INC. | 10% | P - Purchase | $1.55 | +200 | 53.3K | +0.4% | +$310 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-20 | S | D | 53,280 | $4.68 | 0 | I By Sentinel Brokers Company, Inc. | — | — | (F1) Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
| 2 | Common | Common Stock | 2025-03-20 | P | A | 200 | $1.55 | 53,280 | I By Sentinel Brokers Company, Inc. | — | — | (F1) Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
| 3 | Common | Common Stock | 2024-12-02 | S | D | 20 | $2.90 | 53,080 | I By Sentinel Brokers Company, Inc. | — | — | (F1) Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |